Prolonged closure time and defects in von Willebrand factor were identified as risk factors for bleeding complications patients with multiple myeloma. Investigators assess underlying mechanisms and ...
Acquired Factor V inhibitors represent a rare and heterogeneous group of coagulation disorders, characterised by the sudden emergence of autoantibodies that neutralise factor V, a critical cofactor in ...